News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Kamal S. Saini: Enrollment is Ongoing for Phase 3 study CAMBRIA-1
Kamal S. Saini/LinkedIn
May 26, 2024, 08:16

Kamal S. Saini: Enrollment is Ongoing for Phase 3 study CAMBRIA-1

Kamal S. Saini, Executive Medical Director and Head of European Medical Oncology Team at Fortrea Inc., made the following post on LinkedIn

“Approximately 4300 pts will be randomized into the early breast cancer Phase 3 study CAMBRIA-1; enrollment is ongoing!

A phase 3 randomized open-label study of extended adjuvant therapy with camizestrant vs standard endocrine therapy in patients with ER+/HER2– early breast cancer and an intermediate or high risk of recurrence (CAMBRIA 1)
Erika Hamilton; Sibylle Loibl; Naoki Niikura; Priya Rastogi; Kamal S. Saini; Ioanna Gioni; Teresa Klinowska; Ingrid A. Mayer; Mary Stuart; Emilia Syta; Andrew Walding; Thomas Bachelot.”

Kamal S. Saini

Read further.
Source: Kamal S. Saini/LinkedIn
.

4300 pts Andrew Walding CAMBRIA-1 camizestrant cancer early breast cancer Emilia Syta enrollment ongoing ER+/HER2– Erika Hamilton Executive Medical Director extended adjuvant therapy Fortrea Inc. Head of European Medical Oncology Team high risk of recurrence Ingrid A. Mayer intermediate risk Ioanna Gioni Kamal S. Saini Mary Stuart Naoki Niikura OncoDaily Oncology Phase 3 study Priya Rastogi randomized open-label study Sibylle Loibl standard endocrine therapy Teresa Klinowska Thomas Bachelot
Special Coverage
Insight
Aug 6, 2025, 08:31
Lauren Kriger Groner: Textbook Example of Immunotherapy-Induced Sarcoid-Like Granulomatosis
Career
Aug 6, 2025, 08:30
The 2025 ESMO Lifetime Achievement Award Will Be Presented to Rolf A. Stahel - ETOP IBCSG Partners Foundation
Insight
Aug 6, 2025, 08:26
Abubakari Hassan: Economic Burden of Breast Cancer Treatment in Tanzania
Blog
Aug 6, 2025, 08:25
Harpreet Singh: Can We, and Should We, Intervene Earlier in Multiple Myeloma?
Blog
Aug 6, 2025, 08:23
Mahmoud Hammad: 2025 Advanced Treatment of Pediatric Cancers Digital Training Program
Dialogues
Aug 6, 2025, 08:22
Empowering Oncologists: How my cancer journey fueled my passion for becoming an Oncologist?
Blog
Aug 6, 2025, 08:18
Jimmy Turner: Focusing on the Journey and not the Destination
Career
Aug 6, 2025, 08:15
Conquer Cancer, the ASCO Foundation Honored to Welcome Colleen Rosso to the Conquer Cancer Team
Blog
Aug 6, 2025, 08:14
Building Knowledge and Bridging Gaps in Childhood Cancer Survivorship Research Webinar - SIOP
Science
Aug 6, 2025, 08:12
MRD-Guided Strategy in Myeloma - International Society of Liquid Biopsy
Science
Aug 6, 2025, 08:11
Sergio Cifuentes Canaval: Pembrolizumab's Role in Hepatocellular Carcinoma
Insight
Aug 6, 2025, 08:09
Rajat Thawani: The Next Era of Lung Cancer Care